About Sumitomo Pharma
Our challenge for the betterment of healthcare and fuller lives of people worldwide
Our challenge for the betterment of healthcare and fuller lives of people worldwide
Philosophy
Corporate Mission
Philosophy
Corporate Mission
Sumitomo Pharma Group is a member of the Sumitomo Group, which has a history of about 400 years.
We strive to enhance corporate value and contribute to solving social issues under the Sumitomo's Business Philosophy.
For more details about Sumitomo's history and the Sumitomo's Business Philosophy, please visit Sumitomo Group Public Affairs Committee's website.
Corporate MissionTo broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide
Philosophy
Management Mission
Philosophy
Declaration of Conduct
Philosophy
Global slogan
Global slogan
The global slogan reflects our full commitment to deliver to society revolutionary pharmaceuticals, acquired through groundbreaking ideas and high-standard research and development by each individual employee's challenge for innovation, so as to help enable the patients and their families lead healthier and fulfilling lives. It also expresses our corporate mission symbolically.
Sumitomo Pharma possess a rich pipeline, drug discovery capability, leading-edge technology and know-how, broad network related to science.
In addition to our three research focus areas, we work also on infectious diseases and contribute to global health.
Furthermore, we aim to launch the Frontier Business in healthcare areas other than pharmaceuticals, with the aim of providing new solutions to solve social issues.
Strength
Human Resources
Strength
Foundation
In addition to the Psychiatry & Neurology Area, we are focusing on Diabetes and Rare diseases Areas (sales revenue: 149.9 billion yen)
Besides the Psychiatry & Neurology Area, we are focusing on the Respiratory Area (sales revenue: 319.8 billion yen).
Besides the Psychiatry & Neurology Area, we are developing the business with therapeutic agents for bacterial infectious diseases as our main product (sales revenue: 38.3 billion yen).
Strengthened the functions of our subsidiary in Singapore and established local subsidiaries in Thailand and Taiwan and Malaysia.
Collaboration with partners
* Sales revenue is based on FY2021 results
Business Units
In order to deliver innovative and useful pharmaceuticals to people in Japan and around the world, we devote all our efforts to R&D of new pharmaceuticals and providing information on pharmaceuticals with the aim of improving customer satisfaction.
We are also operating a food ingredients and food additives business, and a veterinary medicines business.
Business UnitsAiming Future
We aspire to establish a position as a "Global Specialized Player" with ability to meet increasingly diversified needs for healthcare in 2033.